America September 4, 2025
Novartis $5.2B Deal Chinese Cardio Biotech: Argo Biopharmaceutical and Novartis Expand Collaboration on Cardiovascular RNA Therapies
Argo Biopharmaceutical Co., a pioneering biotechnology company focused on RNA-based medicines, today announced it has entered into a strategic partnership…
